Insights

Poultry Salmonella Opportunity PathogenDx recently launched the Unified Salmonella Testing System and a full D3 Array SalSure suite designed for poultry processing environments. With FSIS intensifying efforts to reduce Salmonella contamination, there are clear sales opportunities with poultry processors, contract labs, hatcheries, and regulatory testing labs. A recommended approach is to target industry events like IPPE 2026, run pilots, and offer integrated detection, quantitation, serotyping, and vaccine-identification capabilities to support faster compliance and lower testing costs.

Fast Multiplex Advantage D3 Array can detect up to 50 pathogens in a single test with rapid turnaround and triplicate data for confidence, while being equipment agnostic. This makes it attractive to clinical and food safety labs seeking higher throughput and lower per-analyte costs. Leverage this in pilots and ROI-driven proposals, emphasizing reduced workflow steps and faster decision-making.

Cloud Enabled Analytics Automated cloud-based analytics enable secure data capture, trend analysis, and regulatory reporting, appealing to labs needing traceability and compliant data management. Position as a scalable data backbone for LIMS integrations and cross-site collaborations within food safety, clinical, and agricultural testing contexts.

Strategic Partnerships The addition of Carl Wittwer to the Board of Advisors signals credibility and opens access to hospital, academic, and large-scale lab networks. Use this to pursue joint development, advisory-led pilots, and multi-site deployments with universities, national labs, and poultry industry associations.

Growth and Channel With mid-sized revenue and a growing product suite, PathogenDx can accelerate sales through distributors and strategic partnerships in food safety and agricultural testing markets, including international expansion. Consider channel-focused campaigns, co-marketing with industry associations, and pilot programs in high-value markets like poultry processing and meat labs.

Similar companies to PathogenDx

PathogenDx Tech Stack

PathogenDx uses 8 technology products and services including Open Graph, TweenMax, Bootstrap, and more. Explore PathogenDx's tech stack below.

  • Open Graph
    Content Management System
  • TweenMax
    Javascript Frameworks
  • Bootstrap
    UI Frameworks
  • HTTP/3
    Web & Portal Technology
  • Contact Form 7
    Web Platform Extensions
  • OpenResty
    Web Servers
  • Facebook
    Widgets
  • Google Plus
    Widgets

Media & News

PathogenDx's Email Address Formats

PathogenDx uses at least 1 format(s):
PathogenDx Email FormatsExamplePercentage
FLast@pathogendx.comJDoe@pathogendx.com
96%
First@pathogendx.comJohn@pathogendx.com
4%

Frequently Asked Questions

What is PathogenDx's phone number?

Minus sign iconPlus sign icon
You can contact PathogenDx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PathogenDx's official website and social media links?

Minus sign iconPlus sign icon
PathogenDx's official website is pathogendx.com and has social profiles on LinkedInCrunchbase.

What is PathogenDx's SIC code NAICS code?

Minus sign iconPlus sign icon
PathogenDx's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PathogenDx have currently?

Minus sign iconPlus sign icon
As of July 2026, PathogenDx has approximately 26 employees across 1 continents, including North America. Key team members include Director Of Sales And Marketing: M. M.Qms Specialist: L. R.Scientific Advisor: C. Y.. Explore PathogenDx's employee directory with LeadIQ.

What industry does PathogenDx belong to?

Minus sign iconPlus sign icon
PathogenDx operates in the Biotechnology Research industry.

What technology does PathogenDx use?

Minus sign iconPlus sign icon
PathogenDx's tech stack includes Open GraphTweenMaxBootstrapHTTP/3Contact Form 7OpenRestyFacebookGoogle Plus.

What is PathogenDx's email format?

Minus sign iconPlus sign icon
PathogenDx's email format typically follows the pattern of FLast@pathogendx.com. Find more PathogenDx email formats with LeadIQ.

How much funding has PathogenDx raised to date?

Minus sign iconPlus sign icon
As of July 2026, PathogenDx has raised $12M in funding. The last funding round occurred on Jan 01, 2022 for $7.5M.
PathogenDx logo

PathogenDx

Biotechnology ResearchArizona, United States11-50 Employees

PathogenDx is a biotechnology company focused on developing testing kits, automation, and software to detect pathogens in plants, food, and humans. Its core multiplex molecular testing technology enables the rapid detection and identification of up to 50 pathogens within a single well, providing triplicate data to support confidence in results and faster decision-making. The system is designed to work with existing laboratory equipment, and analytics are automated through cloud-based software, simplifying workflow and data handling. Together, these capabilities address the needs of clinical, food safety, and agricultural testing by delivering higher throughput and more reliable results.

Headquartered in Scottsdale, Arizona, PathogenDx operates as a small-to-mid-sized biotechnology firm serving labs and producers across clinical, food safety, and agricultural sectors. In January 2026 the company announced a Unified Salmonella Testing System at IPPE 2026, reflecting an expansion of its testing solutions for Salmonella in poultry and related supply chains.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $12M

    PathogenDx has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $7.5Mas a series_unknown.

  • $10M$25M

    PathogenDx's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $12M

    PathogenDx has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $7.5Mas a series_unknown.

  • $10M$25M

    PathogenDx's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.